TargetMol

Sarasinoside A1

Product Code:
 
TAR-TP2437
Product Group:
 
Peptides
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP2437-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP2437-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Sarasinoside A1 is a triterpenoid saponin that reverses mesenchymal tumor transformation.
CAS:
114099-54-6
Molecular Weight:
1289.47
Purity:
0.98
SMILES:
[#6]-[#6](-[#6]-[#6](=O)\[#6]=[#6](\[#6])-[#6])-[#6]1-[#6]-[#6]-[#6]2-[#6]-3=[#6](-[#6]-[#6]C12[#6])C1([#6])[#6]-[#6]-[#6](-[#8]-[#6]-2-[#8]-[#6]-[#6](-[#8]-[#6]-4-[#8]-[#6](-[#6]-[#8])-[#6](-[#8])-[#6](-[#8])-[#6]-4-[#7]-[#6](-[#6])=O)-[#6](-[#8])-[#6]-2-[#8]-[#6]-2-[#8]-[#6](-[#6]-[#8]-[#6]-4-[#8]-[#6](-[#6]-[#8])-[#6](-[#8])-[#6](-[#8])-[#6]-4-[#8]-[#6]-4-[#8]-[#6](-[#6]-[#8])-[#6](-[#8])-[#6](-[#8])-[#6]-4-[#8])-[#6](-[#8])-[#6](-[#8])-[#6]-2-[#7]-[#6](-[#6])=O)C([#6])([#6])[#6]1-[#6]-[#6]-3 |c:13|

References

Dai HF, Edrada RA, Ebel R, Nimtz M, Wray V, Proksch P. Norlanostane triterpenoidal saponins from the marine sponge melophlussarassinorum. J Nat Prod. 2005 Aug;68(8):1231-7. PubMed PMID: 16124767. Kitagawa I, Kobayashi M, Okamoto Y, Yoshikawa M, Hamamoto Y. Structures of sarasinosides A1, B1, and C1; new norlanostane-triterpenoid oligoglycosides from the Palauan marine sponge Asteropus sarasinosum. Chem Pharm Bull (Tokyo). 1987 Dec;35(12):5036-9. PubMed PMID: 3451822. Austin P, Freeman SA, Gray CA, Gold MR, Vogl AW, Andersen RJ, Roberge M, Roskelley CD. The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an E-cadherin-independent manner. Mol Cancer Res. 2013 May;11(5):530-40. doi: 10.1158/1541-7786.MCR-12-0385. Epub 2013 Feb 11. PubMed PMID: 23399642.